Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1438, Issue 3, 1999, Pages 329-348

  Ferretti, Amalia ^a   Knijn, Arno ^a   Iorio, Egidio ^a   Pulciani, Simonetta ^b   Giambenedetti, Massimo ^a   Molinari, Agnese ^c   Meschini, Stefania ^c   Stringaro, Annarita ^c   Calcabrini, Annarica ^c   Freitas, Isabel ^d   Strom, Roberto ^e   Arancia, Giuseppe ^c   Podo, Franca ^a  

^a Ist Superiore San Viale Regina E   (Italy)

^b Laboratory of Virology   (Italy)

^c Laboratory of Ultrastructures   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Electron microscopy; Fibroblast; Fluorescence microscopy; Lipid body; NMR; Ras transformation

Indexed keywords

FAT DROPLET; FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL STRAIN 3T3; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; EMBRYO; FLUORESCENCE MICROSCOPY; LIPID VESICLE; MITOGENESIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOGENE RAS; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; CELL LINE, TRANSFORMED; CHROMATOGRAPHY, GAS; FIBROBLASTS; FLOW CYTOMETRY; FREEZE FRACTURING; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; OXAZINES;

BACTERIA (MICROORGANISMS);

EID: 0033542420     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(99)00071-2     Document Type: Article

References (59)

1. Futerman A.H., Ghidoni R., van Meer G. EMBO Workshop Report 'Lipids: Regulatory Functions in Membrane Traffic and Cell Development'. EMBO J. 17:1998;6772-6775.
2. F.A. Hoffman, Metabolic changes in malignancy, in: L.A. Liotta (Ed.), Influence of Tumor Development on the Host, Kluwer Academic, Dordrecht, 1989, pp. 18-27.
3. C.E. Mountford, C.L. Lena, W.B. Mackinnon, P. Russell, The use of proton MR in cancer pathology, in: G.A. Webbs (Ed.), Annual Reports on NMR Spectroscopy, Vol. 27, Academic Press, New York, 1993, pp. 173-215.
4. F. Podo, J.D. de Certaines (Eds.), Proceedings of the Special Symposium on 'Lipid Metabolism and Function in Cancer. Significance of Magnetic Resonance Spectroscopy (MRS) Measurements in Relation to Biochemical Processes and Cellular Control', Anticancer Res. 16 (1996) 1305-1594.
5. Mountford C.E., Mackinnon W.B., Russell P., Rutter A., Delikatny E.J. Human cancers detected by proton MRS and chemical shift imaging ex vivo. Anticancer Res. 16:1996;1521-1532.
6. 1H NMR visible neutral lipids in activated T lymphocytes: relationship to phosphatidylcholine cycle. Biochim. Biophys. Acta. 1303:1996;215-221.
7. 1H-NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidylcholine-specific phospholipase C. Biochem. Biophys. Res. Commun. 239:1997;868-874.
8. May G.L., Wright L.C., Holmes K.T., Williams P.G., Smith I.C.P., Wright P.E., Fox R.M., Mountford C.E. Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. J. Biol. Chem. 261:1986;3048-3053.
9. Blankenberg F.G., Katsikis P.D., Storrs R.W., Beaulieu C., Spielman D., Chen J.Y., Naumovski L., Tait J.F. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood. 89:1997;3778-3786.
10. 1H magnetic resonance signals from malignant cells do not arise from intracellular lipid droplets. NMR Biomed. 2:1989;161-164.
11. Mountford C.E., Grossman G., Reid G., Fox R.M. Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy. Cancer Res. 42:1982;2270-2276.
12. Mountford C.E., Wright L.C. Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model. Trends Biochem. Sci. 13:1988;172-177.
13. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn. Reson. Med. 29:1993;546-550.
14. 1H Nuclear Magnetic Resonance correspond to lipid droplets. Cancer Res. 57:1997;407-414.
15. Freitas I., Pontiggia P., Barni S., Bertone V., Parente M., Novarina A., Roveta G., Gerzeli G., Stoward P. Histochemical probes for the detection of hypoxic tumour cell. Anticancer Res. 10:1990;613-622.
16. Kuesel A.C., Donnelly S.M., Halliday W., Sutherland G.R., P Smith I.C. Mobile lipids accumulation in necrotic tissue of high grade astrocytomas. Anticancer Res. 16:1996;1485-1490.
17. 1H MRS-visible mobile lipids in H-ras transformed tumorigenic fibroblasts with respect to their untransformed parental cells. Cell. Mol. Biol. 43:1997;691-701.
18. Pulciani S., Santos E., Long L.K., Sorrentino V., Barbacid M. Ras gene amplification and malignant transformation. Mol. Cell. Biol. 5:1985;2836-2841.
19. Barbacid M. Ras genes. Annu. Rev. Biochem. 56:1987;779-827.
20. Barinaga M. From benchtop to bedside. Science. 278:1997;1036-1039.
21. Rutter G., Mackinnon W.B., Huschtscha L.I., Mountford C.E. A proton magnetic resonance spectroscopy study of aging and transformed fibroblasts. Exp. Gerontol. 6:1996;669-686.
22. Halstead J., Kemp K., Ignotz R.A. Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-beta signaling. J. Biol. Chem. 270:1995;13600-13603.
23. Choi G.T.Y., Casu M., Gibbons W.A., lipid profiles of cells N.M.R. tissues and body fluids. Biochem. J. 290:1993;717-721.
24. Delikatny E.J., Lander C.M., Jeitner T.M., Hancock R., Mountford C.E. Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response. Int. J. Cancer. 65:1996;238-245.
25. Delikatny E.J., Roman S.K., Hancock R., Jeitner T.M., Lander C.M., Rideout D.C., Mountford C.E. Tetraphenylphosphonium chloride-induced MR-visible lipid accumulation in a malignant human breast cell line. Int. J. Cancer. 67:1996;72-79.
26. 1H-NMR. Biochim. Biophys. Acta. 1054:1990;198-206.
27. Vanhamme L., van den Boogaart A., van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 129:1997;35-43.
28. A. Van den Boogaart, P. van Hecke, S. van Huffel, D. Graveron-Demilly, D. van Ormondt D, R. de Beer, MRUI: a graphical user interface for accurate routine MRS data analysis, in: MAG*MA, Suppl. Vol. IV, No. II. European Society for Magnetic Resonance in Medicine and Biology, Vienna, 1996, abstr. 784, p. 318.
29. 1H magnetic resonance spectra, in: J.G. McWhirter (Ed.), Mathematics in Signal Processing III, Clarendon Press, Oxford, 1994, pp. 175-195.
30. Greenspan P., Mayer E.P., Fowler S.D. Nile Red: a selective fluorescence stain for intracellular lipid droplets. J. Cell Biol. 100:1985;965-973.
31. Pelech S.L., Vance D.E. Signal transduction via phosphatidylcholine cycles. Trends Biochem. Sci. 14:1989;28-30.
32. Podo F., Ferretti A., Knijn A., Zhang P.J., Ramoni C., Barletta B., Pini C., Baccarini S., Pulciani S. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. Anticancer Res. 16:1996;1399-1422.
33. Fan J.Y., Carpentier J.-L., van Obberghen E., Grunfeld C., Gorden P., Orci L. Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J. Cell Sci. 61:1983;219-230.
34. Koleske A.J., Baltimore D., Lisanti M.P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA. 92:1995;1381-1385.
35. Holmes K.T., Williams P.G., King N.J.C., May G.L., Dyne M., Bloom M., Mountford C.E. A comparison of the chemical analyses of cell lipids with their complete proton NMR spectrum. Magn. Reson. Med. 4:1987;567-574.
36. Bloom M., Holmes K.T., Mountford C.E., Williams P.G. Complete proton magnetic resonance in whole cells. J. Magn. Reson. 69:1986;73-91.
37. Hendriks H.F.J., Brekelmans P.J.A.M., Buytenhek R., Brouwer A., de Leeuw A.M., Knook D.L. Liver parenchymal cells differ from the fat-storing cells in their lipid composition. Lipids. 22:1987;266-273.
38. 1 phase of the cell cycle. Magn. Reson. Med. 16:1990;1-8.
39. Jackowski S. Cell cycle regulation of membrane phospholipid metabolism. J. Biol. Chem. 271:1996;20219-20222.
40. Xu X.X., Tessner T.G., Rock C.O., Jackowski S. Phosphatidylcholine hydrolysis and c-myc expression are in collaborating mitogenic pathways activated by colony-stimulating factor 1. Mol. Cell. Biol. 13:1993;1522-1533.
41. Jackowski S. Coordination of membrane phospholipid synthesis with the cell cycle. J. Biol. Chem. 269:1994;3858-3867.
42. Van Dijk M.C.M., Muriana F.J.G., van der Hoeven P.C.J., de Widt J., Schaap D., Moolenaar W.H., van Blitterswijk W.J. Diacylglycerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: dependence on protein kinase C-ζ Biochem. J. 323:1997;693-699.
43. Verkleij A.J., Zwaal R.F.A., Roelofsen B., Comfurius P., Kastelijn D., van Deenen L.L.M. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta. 323:1973;178-193.
44. Moscat J., Cornet M.E., Diaz-Meco M.T., Larrodera P., Lopez-Alanon D., Lopez-Barahona M. Activation of phosphatidylcholine-specific phospholipase C in cell oncogene transformation. Biochem. Soc. Trans. 17:1989;988-991.
45. Price B.D., Morris J.D.H., Marshall C.J., Hall A. Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation. J. Biol. Chem. 264:1989;16638-16643.
46. Bar-Sagi D., Feramisco J.R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science. 233:1986;1061-1066.
47. Lacal J.C. Regulation of proliferation and apoptosis by Ras and Rho GTPases through specific phospholipid-dependent signaling. FEBS Lett. 410:1997;73-77.
48. Aoki T., Hagiwara H., Fujimoto T. Peculiar distribution of fodrin in fat-storing cells. Exp. Cell Res. 234:1997;313-320.
49. Lieber J.G., Evans R.M. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J. Cell Sci. 109:1996;3047-3058.
50. Blanchette-Mackie E.J., Dwyer N.K., Barber T., Coxey R.A., Takeda T., Rondinone C.M., Theodorakis J.L., Greenberg A.S., Londos C. Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes. J. Lipid Res. 36:1995;1211-1226.
51. Hall P.F., Almahbobi G. Roles of microfilaments and intermediate filaments in adrenal steroidogenesis. Microsc. Res. Tech. 36:1997;463-479.
52. Dvorak A.M., Dvorak H.F., Peters S.P., Shulman E.S., MacGlashan D.W. Jr., Pyne K., Harvey V.S., Galli S.J., Lichtenstein L.M. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J. Immunol. 131:1983;2965-2976.
53. Le Moyec L., Millot G., Tatoud R., Calvo F., Eugène M. Lipid signals detected by NMR proton spectroscopy of whole cells are not correlated to lipid droplets evidenced by the Nile Red staining. Cell. Mol. Biol. 43:1997;703-709.
54. Schneeberger E.E., Lynch R.D., Geyer R.P. Formation and disappearance of triglyceride droplets in strain L fibroblasts. An electron microscopic study. Exp. Cell Res. 69:1971;193-206.
55. Parton R.G., Simons K. Digging into caveolae. Science. 269:1995;1398-1399.
56. Schlegel A., Volonté D., Engelman J.A., Galbiati F., Mehta P., Zhang X.-L., Scherer P.E., Lisanti M.P. Crowded little caves: structure and function of caveolae. Cell. Signal. 10:1998;457-463.
57. Song K.S., Li S., Okamoto T., Quilliam L.A., Sargiacomo M., Lisanti M.P. Co-purification and direct interaction of ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271:1996;9690-9697.
58. Dartsch P.C., Ritter M., Häussinger D., Lang F. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene. Eur. J. Cell Biol. 63:1994;316-325.
59. γ1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinase. Circ. Res. 78:1996;312-321.